MedPath

A clinical trial to study the effect of dexamethasone in patients undergoing middle ear surgery

Not Applicable
Completed
Conditions
Health Condition 1: R739- Hyperglycemia, unspecified
Registration Number
CTRI/2019/02/017570
Lead Sponsor
Jubilee M ission Medical College and Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Patients requiring mastoidectomy and tympanoplasty for Chronic suppurative otitis

media

-ASA(PS),American Society of Anesthesiologists(Physical status) class 1 or 2

-Euthyroid

-Elective surgery

Exclusion Criteria

-Known diabetic patients(fasting blood sugar >126, postprandial blood sugar > 200,

HbA1c > 6.5)

-Chronic steroid therapy

-History of allergy to dexamethasone

-ASA(PS)American Society of Anesthesiologists(Physical status) 3,4

-Pregnancy

-Duration of surgery more than 4 hrs

-h/o gastric or duodenal ulcer

-Significant comorbidities-hepatorenaldysfunction, malignancy, immunosuppression.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycemic profile for 72 hrs after a single dose of dexamethasone in patients <br/ ><br>undergoing middle ear surgeryTimepoint: pre-op and Post op( 2 hours after dexamethasone administration):- <br/ ><br>point-of-care (finger-stick) glucose determinations <br/ ><br> <br/ ><br>ô??¾ POD(Post operative day) 1, 2, 3:- <br/ ><br>Fasting and postprandial point-of-care (finger-stick) glucose determinations
Secondary Outcome Measures
NameTimeMethod
1.Postoperative Nausea and Vomiting <br/ ><br>2.Pain <br/ ><br>3.Fever <br/ ><br>4.Post-operative dizziness <br/ ><br>5.Insulin â?? dose and frequency of administration <br/ ><br>6.Hospital length of stay <br/ ><br>7.Surgical site infectionTimepoint: 1-Incidence of PONV will be noted on POD 1,2,3 <br/ ><br>2:- Pain will be noted on POD 1,2,3 <br/ ><br>3-Fever will be noted on POD 1,2,3 <br/ ><br>4-Dizziness will be noted on POD(Post operative day)1, 2, 3 <br/ ><br>5-At the time of discharge-dose and frequency of insulin administrated <br/ ><br>6. Hospital length of stay- noted at the time of discharge <br/ ><br>7--Surgical site infection will be assessed any point during the <br/ ><br>hospital stay
© Copyright 2025. All Rights Reserved by MedPath